CymaBay Therapeutics, Inc. ( CBAY) - Key Metrics
Stock symbol CBAY is outdated, potentially delisted? Maybe it is available on other exchange?
CBAY Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2023Q4 | $0 | -$0.37 | -$0.24 | -$0.24 |
| 2023Q3 | ? | -$0.32 | -$0.25 | -$0.25 |
| 2023Q2 | $0.30 | -$0.01 | -$0.25 | -$0.25 |
| 2023Q1 | ? | -$0.36 | $0.07 | $0.06 |
| 2022Q4 | ? | -$0.41 | -$0.21 | -$0.21 |
CBAY Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2023Q4 | ? | -15.97 |
| 2023Q3 | ? | -11.63 |
| 2023Q2 | ? | -346.09 |
| 2023Q1 | ? | -6.09 |
| 2022Q4 | ? | -3.78 |
CBAY
Price: $32.48
52 week price:
Earnings Per Share: -0.93 USD
P/E Ratio: -34.58
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 528000
Ebitda: -8.0 millionMarket Capitalization: 3.7 billion